Nexien Biopharma Correlations
| NXEN Stock | USD 0.01 0.01 35.00% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nexien Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nexien Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Nexien Biopharma Correlation With Market
Significant diversification
The correlation between Nexien Biopharma and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nexien Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Nexien |
The ability to find closely correlated positions to Nexien Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nexien Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nexien Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nexien Biopharma to buy it.
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nexien Pink Sheet performing well and Nexien Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nexien Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EDXC | 6.12 | (0.06) | 0.00 | 0.17 | 0.00 | 15.38 | 32.23 | |||
| CHOOF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CANN | 5.55 | (0.36) | 0.00 | 0.29 | 0.00 | 11.47 | 44.14 | |||
| CVSI | 4.10 | (0.05) | 0.00 | 0.07 | 6.56 | 25.00 | 45.00 | |||
| LOVFF | 2.54 | 0.28 | 0.00 | (0.10) | 4.38 | 8.51 | 36.67 | |||
| SNOA | 5.41 | (0.70) | 0.00 | (0.17) | 0.00 | 13.88 | 40.82 | |||
| MSMY | 6.66 | 0.44 | 0.03 | 0.55 | 7.42 | 16.67 | 58.33 | |||
| UNRV | 1.51 | 0.16 | 0.00 | 0.34 | 0.00 | 0.00 | 83.33 | |||
| GSAC | 11.20 | 2.04 | 0.07 | (1.07) | 11.12 | 33.33 | 58.33 | |||
| AQST | 3.34 | 0.00 | 0.02 | 0.12 | 3.80 | 6.51 | 20.28 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nexien Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Nexien Biopharma Corporate Management
| Joseph Morgan | Consultant | Profile | |
| Esq JD | Chief Officer | Profile | |
| Richard Greenberg | CEO, Founder | Profile | |
| Evan CPA | Chief Officer | Profile | |
| Paul Wilkenson | Consultant | Profile | |
| Linda Klumpers | Consultant | Profile |